SCHEMBL3175679

SCHEMBL3175679

O=C(O)COc1cccc(/C=C/CO)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.54
PPARG P37231 4/20 0.53
PPARA Q07869 4/20 0.53
ACMSD Q8TDX5 1/20 0.52
ALOX15 P16050 1/20 0.51
PTPN7 P35236 1/20 0.51
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
EPOR P19235 2/20 0.50
PKM P14618 1/20 0.49
MAPK1 P28482 1/20 0.46
ALOX5 P09917 1/20 0.45
ALOX5AP P20292 1/20 0.45
PTGS1 P23219 1/20 0.45
PTGS2 P35354 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
CYSLTR2 Q9NS75 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175689 1.00 LMNA (0.54) LMNAPPARGPPARAACMSDALOX15
SCHEMBL14143474 0.87 KDM4E (0.57) LMNAPPARGPPARAACMSDALOX15
SCHEMBL4683421 0.87 LMNA (0.53) LMNAPPARGPPARAACMSDALOX15
SCHEMBL3165159 0.87 LMNA (0.53) LMNAPPARGPPARAACMSDALOX15
SCHEMBL3165146 0.87 LMNA (0.53) LMNAPPARGPPARAACMSDALOX15
SCHEMBL4683425 0.87 LMNA (0.53) LMNAPPARGPPARAACMSDALOX15
SCHEMBL9813018 0.87 LMNA (0.53) LMNAPPARGPPARAACMSDALOX15
SCHEMBL9813016 0.87 LMNA (0.53) LMNAPPARGPPARAACMSDALOX15
SCHEMBL14501312 0.84 CYSLTR2 (0.59) LMNAPPARGPPARAKDM4EALDH1A1
SCHEMBL4416397 0.83 ALOX15 (0.61) LMNAPPARGPPARAACMSDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273745-B2 Polycyclic acid compounds useful as CRTH2 antagonists and antiallergic agents ASTELLAS PHARMA INC (JP) 2012-09-25 US disclosed
EP-2094662-B1 POLYCYCLIC ACID COMPOUNDS USEFUL AS CRTH2 ANTAGONISTS AND ANTIALLERGIC AGENTS ASTELLAS PHARMA INC (JP) 2012-04-11 EP disclosed
US-20100009991-A1 POLYCYCLIC ACID COMPOUNDS USEFUL AS CRTH2 ANTAGONISTS AND ANTIALLERGIC AGENTS ASTELLAS PHARMA INC. (JP) 2010-01-14 US disclosed
EP-1386913-B1 PYRROLE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO (JP) 2008-07-16 EP disclosed
US-7220773-B2 Heterocylic amines used as antidiabetic or hyperglycemic agents DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-05-22 US disclosed
US-20040162331-A1 Pyrrole derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2004-08-19 US disclosed
EP-1386913-A1 PYRROLE DERIVATIVE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009991-A1 POLYCYCLIC ACID COMPOUNDS USEFUL AS CRTH2 ANTAGONISTS AND ANTIALLERGIC AGENTS HRH2, HRH1, HRH4 LMNA 4586/4885PPARG 1069/4885PPARA 1122/4885
US-20040162331-A1 Pyrrole derivative SLC5A1, GLP1R, SLC5A2 LMNA 4783/4885PPARG 126/4885PPARA 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.